Shanghai Investments vs End Period Cash Flow Analysis

688293 Stock

42.98 0.20 0.47%

Shanghai OPM financial indicator trend analysis is much more than just breaking down Shanghai OPM Biosciences prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Shanghai OPM Biosciences is a good investment. Please check the relationship between Shanghai OPM Investments and its End Period Cash Flow accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Shanghai OPM Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Investments vs End Period Cash Flow

Investments vs End Period Cash Flow Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Shanghai OPM Biosciences Investments account and End Period Cash Flow. At this time, the significance of the direction appears to have pay attention.

The correlation between Shanghai OPM's Investments and End Period Cash Flow is -0.82. Overlapping area represents the amount of variation of Investments that can explain the historical movement of End Period Cash Flow in the same time period over historical financial statements of Shanghai OPM Biosciences, assuming nothing else is changed. The correlation between historical values of Shanghai OPM's Investments and End Period Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Investments of Shanghai OPM Biosciences are associated (or correlated) with its End Period Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when End Period Cash Flow has no effect on the direction of Investments i.e., Shanghai OPM's Investments and End Period Cash Flow go up and down completely randomly.

Correlation Coefficient

-0.82

Relationship Direction	Negative
Relationship Strength	Significant

View All Relationships

Investments

Securities or assets acquired for generating income or appreciating in value, not used in daily operations.

End Period Cash Flow

Most indicators from Shanghai OPM's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Shanghai OPM Biosciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Shanghai OPM Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

The current year's Tax Provision is expected to grow to about 11.1 M, whereas Selling General Administrative is forecasted to decline to about 30.7 M.

	2021	2022	2023	2024 (projected)
Interest Expense	4.8M	5.0M	3.2M	4.2M
Interest Income	4.9M	13.8M	23.2M	12.1M

Interest Expense Interest Income

Shanghai OPM fundamental ratios Correlations

	Net Debt	Long Term Debt	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Capital Lease Obligations	Inventory	Other Current Assets	Total Liab	Net Invested Capital	Property Plant And Equipment Gross	Short Long Term Debt	Total Current Assets	Capital Stock	Net Working Capital	Intangible Assets
Net Debt		0.63	-0.58	0.17	-0.47	-0.57	-0.64	-0.55	-0.68	-0.53	-0.68	-0.68	-0.65	-0.69	0.87	0.66	-0.61	-0.6	-0.49	-0.57	-0.66	0.58	-0.55	-0.72	-0.54	0.97
Long Term Debt	0.63		-0.98	0.4	-0.72	-0.98	-0.97	-0.96	-0.92	-0.97	-0.97	-0.96	-0.98	-0.98	0.75	0.57	-0.93	-0.91	-0.61	-0.98	-0.98	0.25	-0.98	-0.93	-0.97	0.67
Total Assets	-0.58	-0.98		-0.45	0.72	1.0	0.98	0.97	0.9	0.99	0.96	0.94	0.98	0.99	-0.74	-0.58	0.93	0.9	0.6	1.0	0.98	-0.22	1.0	0.91	1.0	-0.64
Other Current Liab	0.17	0.4	-0.45		0.22	-0.47	-0.53	-0.26	-0.29	-0.51	-0.31	-0.34	-0.41	-0.47	0.6	0.17	-0.09	-0.01	0.35	-0.46	-0.44	0.65	-0.47	-0.36	-0.5	0.25
Total Current Liabilities	-0.47	-0.72	0.72	0.22		0.7	0.6	0.86	0.61	0.69	0.71	0.64	0.67	0.7	-0.4	-0.71	0.9	0.92	0.98	0.71	0.66	0.36	0.72	0.57	0.7	-0.56
Total Stockholder Equity	-0.57	-0.98	1.0	-0.47	0.7		0.98	0.97	0.9	0.99	0.96	0.94	0.98	0.99	-0.74	-0.56	0.92	0.89	0.58	1.0	0.98	-0.24	1.0	0.91	1.0	-0.63
Property Plant And Equipment Net	-0.64	-0.97	0.98	-0.53	0.6	0.98		0.91	0.94	0.97	0.97	0.97	0.99	0.98	-0.79	-0.49	0.88	0.84	0.47	0.98	0.99	-0.4	0.97	0.96	0.97	-0.66
Retained Earnings	-0.55	-0.96	0.97	-0.26	0.86	0.97	0.91		0.85	0.96	0.93	0.89	0.94	0.95	-0.66	-0.65	0.97	0.96	0.76	0.97	0.93	-0.02	0.97	0.84	0.96	-0.63
Accounts Payable	-0.68	-0.92	0.9	-0.29	0.61	0.9	0.94	0.85		0.86	0.98	0.99	0.97	0.9	-0.67	-0.35	0.89	0.87	0.5	0.9	0.96	-0.38	0.87	1.0	0.87	-0.63
Cash	-0.53	-0.97	0.99	-0.51	0.69	0.99	0.97	0.96	0.86		0.92	0.91	0.96	0.98	-0.74	-0.6	0.9	0.86	0.57	1.0	0.96	-0.21	1.0	0.86	1.0	-0.61
Non Current Assets Total	-0.68	-0.97	0.96	-0.31	0.71	0.96	0.97	0.93	0.98	0.92		1.0	0.99	0.95	-0.71	-0.47	0.94	0.93	0.6	0.96	0.99	-0.3	0.94	0.98	0.94	-0.66
Non Currrent Assets Other	-0.68	-0.96	0.94	-0.34	0.64	0.94	0.97	0.89	0.99	0.91	1.0		0.99	0.94	-0.71	-0.42	0.91	0.89	0.53	0.94	0.99	-0.37	0.92	0.99	0.92	-0.65
Net Receivables	-0.65	-0.98	0.98	-0.41	0.67	0.98	0.99	0.94	0.97	0.96	0.99	0.99		0.98	-0.75	-0.49	0.93	0.9	0.56	0.98	1.0	-0.33	0.97	0.97	0.97	-0.66
Common Stock Shares Outstanding	-0.69	-0.98	0.99	-0.47	0.7	0.99	0.98	0.95	0.9	0.98	0.95	0.94	0.98		-0.83	-0.65	0.91	0.88	0.59	0.99	0.98	-0.32	0.98	0.91	0.98	-0.75
Non Current Liabilities Total	0.87	0.75	-0.74	0.6	-0.4	-0.74	-0.79	-0.66	-0.67	-0.74	-0.71	-0.71	-0.75	-0.83		0.74	-0.61	-0.56	-0.35	-0.74	-0.76	0.65	-0.73	-0.73	-0.74	0.92
Capital Lease Obligations	0.66	0.57	-0.58	0.17	-0.71	-0.56	-0.49	-0.65	-0.35	-0.6	-0.47	-0.42	-0.49	-0.65	0.74		-0.61	-0.59	-0.73	-0.57	-0.5	0.02	-0.59	-0.37	-0.58	0.82
Inventory	-0.61	-0.93	0.93	-0.09	0.9	0.92	0.88	0.97	0.89	0.9	0.94	0.91	0.93	0.91	-0.61	-0.61		1.0	0.82	0.92	0.92	0.0	0.91	0.86	0.9	-0.65
Other Current Assets	-0.6	-0.91	0.9	-0.01	0.92	0.89	0.84	0.96	0.87	0.86	0.93	0.89	0.9	0.88	-0.56	-0.59	1.0		0.85	0.89	0.89	0.05	0.88	0.84	0.87	-0.63
Total Liab	-0.49	-0.61	0.6	0.35	0.98	0.58	0.47	0.76	0.5	0.57	0.6	0.53	0.56	0.59	-0.35	-0.73	0.82	0.85		0.59	0.54	0.4	0.59	0.46	0.57	-0.57
Net Invested Capital	-0.57	-0.98	1.0	-0.46	0.71	1.0	0.98	0.97	0.9	1.0	0.96	0.94	0.98	0.99	-0.74	-0.57	0.92	0.89	0.59		0.98	-0.23	1.0	0.9	1.0	-0.63
Property Plant And Equipment Gross	-0.66	-0.98	0.98	-0.44	0.66	0.98	0.99	0.93	0.96	0.96	0.99	0.99	1.0	0.98	-0.76	-0.5	0.92	0.89	0.54	0.98		-0.35	0.97	0.97	0.97	-0.67
Short Long Term Debt	0.58	0.25	-0.22	0.65	0.36	-0.24	-0.4	-0.02	-0.38	-0.21	-0.3	-0.37	-0.33	-0.32	0.65	0.02	0.0	0.05	0.4	-0.23	-0.35		-0.2	-0.46	-0.22	0.48
Total Current Assets	-0.55	-0.98	1.0	-0.47	0.72	1.0	0.97	0.97	0.87	1.0	0.94	0.92	0.97	0.98	-0.73	-0.59	0.91	0.88	0.59	1.0	0.97	-0.2		0.88	1.0	-0.62
Capital Stock	-0.72	-0.93	0.91	-0.36	0.57	0.91	0.96	0.84	1.0	0.86	0.98	0.99	0.97	0.91	-0.73	-0.37	0.86	0.84	0.46	0.9	0.97	-0.46	0.88		0.88	-0.66
Net Working Capital	-0.54	-0.97	1.0	-0.5	0.7	1.0	0.97	0.96	0.87	1.0	0.94	0.92	0.97	0.98	-0.74	-0.58	0.9	0.87	0.57	1.0	0.97	-0.22	1.0	0.88		-0.62
Intangible Assets	0.97	0.67	-0.64	0.25	-0.56	-0.63	-0.66	-0.63	-0.63	-0.61	-0.66	-0.65	-0.66	-0.75	0.92	0.82	-0.65	-0.63	-0.57	-0.63	-0.67	0.48	-0.62	-0.66	-0.62

Click cells to compare fundamentals

Shanghai OPM Account Relationship Matchups

Currently Active Assets on Macroaxis

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America
S	SentinelOne
WD	Walker Dunlop

Other Information on Investing in Shanghai Stock

Balance Sheet is a snapshot of the financial position of Shanghai OPM Biosciences at a specified time, usually calculated after every quarter, six months, or one year. Shanghai OPM Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Shanghai OPM and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Shanghai currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Shanghai Investments vs End Period Cash Flow Analysis

Investments vs End Period Cash Flow

Investments vs End Period Cash Flow Correlation Analysis

Correlation Coefficient

Investments

End Period Cash Flow

Shanghai OPM fundamental ratios Correlations

Shanghai OPM Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Currently Active Assets on Macroaxis

Other Information on Investing in Shanghai Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Net Invested Capital	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Net Working Capital	+ 1.0	Total Assets
Net Invested Capital	+ 1.0	Total Stockholder Equity
Total Current Assets	+ 1.0	Total Stockholder Equity

Total Current Assets	- 0.98	Long Term Debt
Property Plant And Equipment Gross	- 0.98	Long Term Debt
Net Invested Capital	- 0.98	Long Term Debt
Common Stock Shares Outstanding	- 0.98	Long Term Debt
Net Receivables	- 0.98	Long Term Debt
Total Stockholder Equity	- 0.98	Long Term Debt